Neogen (NEOG)
(Delayed Data from NSDQ)
$4.66 USD
+0.01 (0.22%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $4.67 +0.01 (0.21%) 7:58 PM ET
5-Strong Sell of 5 5
B Value B Growth D Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NEOG 4.66 +0.01(0.22%)
Will NEOG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NEOG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NEOG
Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Neogen (NEOG) Q4 Earnings Lag Estimates
NEOG: What are Zacks experts saying now?
Zacks Private Portfolio Services
InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Earnings Preview: Neogen (NEOG) Q4 Earnings Expected to Decline
ResMed (RMD) Up 4% Since Last Earnings Report: Can It Continue?
Other News for NEOG
Neogen Corp (NEOG) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Q4 2025 Neogen Corp Earnings Call Transcript
Neogen reports Q4 adjusted EPS 5c, consensus 9c
Neogen sees FY26 revenue $820M-$840M, consensus $803M
NEOG Announces FY26 Financial Projections with Focus on EBITDA and Reduced Expenditures